Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Ideaya Biosciences (IDYA) PT Raised to $63 at Stifel
-
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY)
-
Science Applications (SAIC) PT Lowered to $125 at Truist Securities
-
-
-
-
-
-
-
Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
-
-
-
-
-
-
-
Citi Resumes Sensei Biotherapeutics (SNSE) at Buy, 'Initial SNS-101 Efficacy Data at ASCO Suggest Early Clinical Activity'
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on SQM (SQM)
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Arcus Biosciences (RCUS)
-
-
-
-
-
-
-
Keefe, Bruyette & Woods Reiterates Outperform Rating on American International Group (AIG)
-
-
-
-
-
-
-
Roth/MKM Reiterates Buy Rating on Bio-Path Holdings (BPTH)
-
-
-
-
-
359,717 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.